Suven Life Sciences Limited (SUVEN.NS)

INR 142.78

(-0.61%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 2.84 Billion 3.88 Billion 1.08 Billion 1.28 Billion 1.81 Billion 10.38 Billion
Total Current Assets 2.56 Billion 2.51 Billion 665.94 Million 1.02 Billion 659.86 Million 6.23 Billion
Cash And Short Term Investments 2.39 Billion 2.35 Billion 504.35 Million 463.53 Million 147.25 Million 2.42 Billion
Cash and Cash Equivalents 1.63 Billion 370.19 Million 52.73 Million 93.48 Million 146.75 Million 111.31 Million
Short Term Investments 759.35 Million 1.98 Billion 451.62 Million 370.05 Million 494 Thousand 2.31 Billion
Net Receivables 12.86 Million 77.69 Million 161.36 Million 561.85 Million -2.89 Million 527.24 Million
Inventory 7.08 Million 79 Thousand 224 Thousand 1.41 Million 2.89 Million 1.57 Billion
Other Current Assets 147.64 Million 84.23 Million -2000.00 2000.00 512.61 Million 2.23 Billion
Total Non-Current Assets 282.29 Million 1.37 Billion 414.4 Million 257.36 Million 1.15 Billion 4.15 Billion
Net PPE 280.09 Million 370.16 Million 408.9 Million 256 Million 245.42 Million 4.01 Billion
Good Will And Intangible Assets 1.98 Million 1.98 Million 2.24 Million 1.36 Million 1.51 Million 26.85 Million
Good Will - - - - - -
Intangible Assets 1.98 Million 1.98 Million 2.24 Million 1.36 Million 1.51 Million 26.85 Million
Long-Term Investments 150 Thousand 1 Billion - -857 Thousand 912.52 Million -2.31 Billion
Tax Assets -1.00 150 Thousand - 258.22 Million 9.91 Million 2.43 Billion
Other Non Current Assets 59 Thousand 949 Thousand 3.25 Million -257.36 Million -9.91 Million 1000.00
Other Assets 1.00 - - - - -
Total Liabilities 148.62 Million 135.91 Million 118.89 Million 204.12 Million 385.84 Million 2.07 Billion
Total Current Liabilities 135.16 Million 111.29 Million 83.14 Million 159.09 Million 265.11 Million 1.49 Billion
Account Payables 20.68 Million 16.64 Million 19.86 Million 29.95 Million 57.82 Million 606.6 Million
Tax Payables - - - - - -
Short Term Debt 7.09 Million 10.26 Million 16.35 Million 20.45 Million 19.92 Million 362.36 Million
Deferred Revenue - 78.93 Million 40.9 Million 101.64 Million 184.45 Million 518.1 Million
Other Current Liabilities 107.38 Million 5.45 Million 6.02 Million 7.04 Million 2.9 Million 3 Million
Total Non Current Liabilities 13.46 Million 24.61 Million 35.74 Million 45.02 Million 120.72 Million 588.84 Million
Long-Term Debt - 5.79 Million 15.73 Million 27.18 Million 40.19 Million 17.75 Million
Deferred Revenue Non Current - - - - 17.2 Million 74.31 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 13.46 Million 18.82 Million 20.01 Million 17.84 Million 4.66 Million 7.57 Million
Other Liabilities - - - - - -
Total Equity 2.7 Billion 3.75 Billion 961.45 Million 1.08 Billion 1.43 Billion 8.3 Billion
Stock Holders Equity 2.7 Billion 3.75 Billion 961.45 Million 1.08 Billion 1.43 Billion 8.3 Billion
Common Stock 218.07 Million 218.07 Million 145.38 Million 127.28 Million 127.28 Million 127.28 Million
Retained Earnings -4.39 Billion -3.34 Billion -2.16 Billion -945.08 Million -220.5 Million 4.65 Billion
Accumulated other comprehensive income 2.48 Billion 414.62 Million 416.14 Million 789.71 Million -189.2 Million -930 Million
Common Stock Equity 2.7 Billion 3.75 Billion 961.45 Million 1.08 Billion 1.43 Billion 8.3 Billion
Capital Lease Obligation 7.09 Million 16.05 Million 27.24 Million 34.27 Million 39.83 Million 29.35 Million
Total Investments 759.5 Million 1 Billion 451.62 Million 369.2 Million 494 Thousand 705 Thousand
Total Debt 7.09 Million 16.05 Million 32.08 Million 47.63 Million 60.12 Million 380.11 Million
Net Debt -1.63 Billion -354.13 Million -20.65 Million -45.84 Million -86.63 Million 268.8 Million

Balance Sheet Charts